Status:
NOT_YET_RECRUITING
Single Cell Acute Leukemia Analysis
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Acute Myeloid Leucemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Numerous chemotherapy and immunotherapy resistance genes have been identified in cancers in general and acute myeloid leukemia in particular. As a preliminary to this study, the investigators hypothes...
Eligibility Criteria
Inclusion
- Adult patient
- Patient who has received information about the study and has not expressed opposition,
- Patients who are beneficiaries of a social security plan,
- Patient with relapsed or refractory acute myeloid leukemia, whatever the previous treatment, the therapeutic line and the time between the previous treatment and the relapse.
Exclusion
- Persons who do not understand the French language if there is no translator available to translate for them.
- Absence of circulating blastosis.
Key Trial Info
Start Date :
July 31 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2029
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06906978
Start Date
July 31 2025
End Date
July 31 2029
Last Update
April 10 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.